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Pregnancy is associated with progressive hypercholanemia, hypercholesterolemia, and hypertriglyceridemia, which can 
result in metabolic disease in susceptible women. Gut signals modify hepatic homeostatic pathways, linking intesti-
nal content to metabolic activity. We sought to identify whether enteric endocrine signals contribute to raised serum 
bile acids observed in human and murine pregnancies, by measuring fibroblast growth factor (FGF) 19/15 protein 
and mRNA levels, and 7α-hydroxy-4-cholesten-3-one. Terminal ileal farnesoid X receptor (FXR)-mediated gene ex-
pression and apical sodium bile acid transporter (ASBT) protein concentration were measured by qPCR and western 
blotting. Shotgun whole-genome sequencing and ultra-performance liquid chromatography tandem mass spectrom-
etry were used to determine the cecal microbiome and metabonome. Targeted and untargeted pathway analyses were 
performed to predict the systemic effects of the altered metagenome and metabolite profiles. Dietary CA supplemen-
tation was used to determine whether the observed alterations could be overcome by intestinal bile acids functioning 
as FXR agonists. Human and murine pregnancy were associated with reduced intestinal FXR signaling, with lower 
FGF19/15 and resultant increased hepatic bile acid synthesis. Terminal ileal ASBT protein was reduced in murine 
pregnancy. Cecal bile acid conjugation was reduced in pregnancy because of elevated bile salt hydrolase-producing 
Bacteroidetes. CA supplementation induced intestinal FXR signaling, which was not abrogated by pregnancy, with 
strikingly similar changes to the microbiota and metabonome as identified in pregnancy. Conclusion: The altered in-
testinal microbiota of pregnancy enhance bile acid deconjugation, reducing ileal bile acid uptake and lowering FXR 
induction in enterocytes. This exacerbates the effects mediated by reduced bile acid uptake transporters in preg-
nancy. Thus, in pregnant women and mice, there is reduced FGF19/15-mediated hepatic repression of hepatic bile 
acid synthesis, resulting in hypercholanemia. (Hepatology 2019;0:1-18).
In normal human pregnancy, there is a change in metabolism with advancing gestation that results in elevated serum bile acids,(1) hypercholesterolemia, and hypertriglyceridemia(2) in the third trimester. These gestational alterations in lipid metabolism are essential to ensure nutrient provision for the growing 
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fetus and are associated with altered expression of 
key genes in pathways that control bile acid and lipid 
homeostasis. Serum and hepatocyte bile acid con-
centrations are elevated on day 18 of murine preg-
nancy,(3,4) likely secondary to gestational increases 
in 17β-estradiol(5) and sulfated progesterone metab-
olites.(6) These endocrine changes cause reduced 
function of hepatic farnesoid X receptor (FXR); the 
sulfated progesterone metabolite, epiallopregnanolone 
sulfate (PM5S), is a partial agonist of FXR,(7) whereas 
17β-estradiol–bound estrogen receptor α directly 
interacts with FXR to repress downstream transcrip-
tion.(5) Bile acids also signal through enterocyte and 
enteroendocrine L-cell receptors to influence bile acid 
homeostasis and the release of hormones that impact 
gestational lipid and bile acid metabolism. Activated 
FXR in enterocytes dimerizes with retinoid X recep-
tor (RXR), causing induction of rodent ileal bile acid 
binding protein,(8) organic solute transporters (OSTs; 
OSTα and OSTβ),(9) secretion of the hormone fibro-
blast growth factor (FGF) 15 in mice, FGF19 in 
humans,(10) and small heterodimer partner (SHP)-
mediated repression of apical sodium-dependent bile 
acid transporter (ASBT).(11) Bile-acid–binding and 
activation of the G-protein-coupled receptor, Takeda 
G-protein-coupled receptor 5 (TGR5), expressed by 
enteroendocrine cells within the gut, results in release 
of glucagon-like peptide 1 (GLP1).(12) Thus, luminal 
bile acids have a profound effect on bile acid, lipid, 
and glucose homeostasis through interaction with dif-
ferent receptors in a range of tissues.(13)
The composition of the gut microbiota influ-
ences the luminal concentration and conjugation 
of specific bile acids and consequent expression of 
enzymes that control intestinal and hepatic bile acid 
transport and metabolism through FXR-dependent 
pathways (reviewed in a previous work(14)). In brief, 
when compared to germ-free mice, convention-
ally reared animals had higher serum and fecal bile 
acid concentrations, more deconjugated bile acids 
in the distal gut, and a lower proportion of taurine- 
conjugated bile acids in the proximal and distal 
gut(15) and other tissues, including the kidney and 
heart.(16) The potency of bile acid species as FXR 
agonists differs,(17) chenodeoxycholic acid (CDCA), 
cholic acid (CA) and their taurine conjugates are 
FXR agonists, whereas the taurine-conjugated α and 
β muricholic acids (MCAs) are FXR antagonists.(15) 
Furthermore, alterations in the luminal concentra-
tion of specific bile acids will affect the abundance of 
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particular microbes within the gut lumen; for exam-
ple, Bilophila wadsworthia grows preferentially in the 
presence of high bile acid concentrations,(18) whereas 
deoxycholic acid (DCA) and CDCA are toxic to 
the growth of Bif idobacterium breve, Blautia coccoides 
JCM 1395T, and Bacteroides thetaiotaomicron DSM 
2079T.(19) FXR activity in the intestine has been 
shown to regulate bacterial growth: Administration 
of the synthetic FXR agonist, GW4064, after bile 
duct ligation (when bacterial overgrowth is com-
mon) reduced both aerobic and anaerobic bacteria 
in the ileum and cecum; this effect did not occur in 
Fxr–/– mice.(20)
Studies of pregnancy typically demonstrate alter-
ations in the intestinal gut microbiota through gesta-
tion; two human studies reported marked alterations 
in the third trimester compared with the first,(21,22) 
with resultant metabolic changes when third trimes-
ter feces was used to colonize germ-free mice.(21) A 
longitudinal study in mice demonstrated that changes 
to the gut microbiota occurred early in gestation(23); 
however, a longitudinal human study of 49 women 
did not show gestational alterations in gut bacterial 
composition.(24)
In this study, we sought to determine whether 
altered enterohepatic feedback contributes to the 
hypercholanemia of pregnancy, including whether 
gestational alterations in the human gut microbi-
ota and intestinal metabonome could contribute. We 
then utilized a murine model of CA feeding, which 
has similar phenotypic differences in lipid composi-
tion and hepatic steatosis to pregnancy,(3) to establish 
whether enterocyte exposure to an FXR ligand abro-
gated these gestational effects.
Materials and Methods
HUMaN SaMpleS
The study conformed to the 1975 Declaration of 
Helsinki guidelines; permission was obtained from the 
ethics committees of Hammersmith Hospitals NHS 
Trust, London (08/H0707/21 and 11/LO/0396) and 
Sahlgrenska University Hospital, Gothenburg (Dnr 
536-14). Written informed consent was received from 
participants before inclusion.
Fecal samples were obtained from 14 women 
with uncomplicated pregnancies and 9 nonpregnant 
healthy women. Women were restricted to those with 
spontaneously conceived third trimester singleton 
pregnancies, without pregnancy complications and 
who had not taken antibiotics for the duration of the 
pregnancy. Fecal samples were frozen at −80oC within 
24 hours of collection.
Serum samples for analysis of FGF19 and 7α- 
hydroxy-4-cholesten-3-one (C4) were taken from 
women given a standardized diet from 6:00 pm the 
preceding day, with venepuncture performed at 8:00 
am (fasting) and 3:00 pm. Participants were given fixed 
meals at 6:00 pm, 8:00 am, and 12:00 pm and remained 
sedentary throughout. Of the participants, 14 were non-
pregnant (with previously uncomplicated pregnancies) 
and 24 had uncomplicated pregnancies. Blood samples 
were obtained in Vacutainer Serum Separation Tubes 
and after 30  minutes were centrifuged at 1,700g for 
10 minutes. Serum was aliquoted and stored at −80oC. 
Serum analyses for FGF19 and C4 were performed 
as described,(25) using enzyme-linked immunosorbent 
assay (ELISA; FGF19 Quantikine ELISA kit, Cat. 
No. DF1900; R&D Systems, Minneapolis, MN), and 
high-performance liquid chromatography following 
solid-phase extraction for C4.
aNIMal HaNDlINg
Experiments were conducted according to the UK 
Animals (Scientific Procedures) Act of 1986 and with 
protocols approved by the King’s College London 
Animal Studies Committee. Female C57BL/6 mice 
(Charles River, Wilmington, MA) were housed in 
the same room within clean facilities, with a 12-hour 
light cycle. Cages housed 3 mice per cage, all from 
the same dietary group. Mice were fed a normal chow 
diet (RM3 control diet, Special Diets Services, Essex, 
UK) ad libitum until mating, at which time half the 
mice had a diet supplemented with 0.5% CA (LBS 
Biotechnology, Horley, UK) until delivery. Mice were 
sacrificed on day 0 or day 18 of pregnancy, resulting 
in n  =  6-8 per group. Separate cohorts of C57BL/6 
mice were sacrificed at increasing gestational ages 
(days 2, 7, 10, 14, and 18; n = 6-7 per time point), as 
described.(26)
At sacrifice, murine ceca, ileum, duodenum, gall 
bladder, and liver were harvested and snap frozen 
on dry ice and subsequently stored at −80oC. While 
frozen, ceca were longitudinally split and content dis-
sected from overlying intestinal tissue.
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DNa eXtRaCtIoN
DNA was extracted from cecal content using Qiagen 
Tissuelyser II bead beating and a QiaAMP Fast DNA 
Stool Mini Kit (Qiagen, Venlo, Netherlands), accord-
ing to the manufacturer’s instructions.
MetageNoMICS aNalySIS
The 29 murine samples of extracted DNA were 
treated with a PowerClean DNA Clean-Up Kit 
(Mo Bio, Carlsbad, CA), as per the manufacturer’s 
instructions. Samples were sequenced by The Genome 
Analysis Centre (TGAC, Norwich, UK) using an 
Illumina HiSeq 2500 platform (Illumina, San Diego, 
CA) in paired-end mode, with typical read lengths 
85-150 base pairs. Samples were checked using 
FastQC(27) to assure the global quality of the sequenc-
ing, and only one sample (nonpregnant, chow fed) was 
removed thereafter, leaving n = 6-8 per group.
An in-house metagenomics analysis pipeline was 
developed as described,(28) introducing the removal of 
the repeat masking step and inclusion of the assem-
bly step using IDBA-UD software(29) (Supporting 
Fig. S1). Methods for this are included in the 
Supporting Information.
MetataXoNoMIC aNalySIS 
(16S RIBoSoMal RNa geNe 
SeQUeNCINg)
Metataxonomics was performed by Research and 
Testing, Lubbock, Texas. Taxonomic identification 
of sequences was performed using QIIME software 
referencing the GreenGenes library, with statisti-
cal results analysis using STAMP and R. P values 
were adjusted for multiple comparisons using the 
Benjamini-Hochberg method in R programming 
software.
MetaBolIC pRoFIlINg
Aqueous and organic extractions were performed 
for cecum, cecal content, gall bladder, and liver sam-
ples as detailed in the Supporting Information. These 
were assessed with reversed-phase ultra-performance 
liquid chromatography tandem mass spectrometry 
(UPLC-MS/MS) lipid profiling of organic extracts, 
hydrophilic interaction chromatography UPLC-MS/
MS profiling of aqueous extracts, and bile acid 
UPLC-MS/MS profiling of combined aqueous and 
organic extracts.
Data pRepRoCeSSINg aND 
StatIStICal aNalySIS oF 
MetaBolIC pRoFIlINg
MS raw data were converted to netCDF format 
using the DataBridge tool implemented in MassLynx 
software (Waters Corporation, Milford, MA). Data 
were processed using the XCMS package in R (https ://
www.r-proje ct.org/), and an output table was obtained 
comprising pairs of m/z_RT (mass to charge ratio _ 
retention time) and intensity values of the detected 
metabolite features in each sample. The data set was 
normalized to total area normalization. Multivariate 
data analysis was performed using the SIMCA package 
(v.13.0.2; Umetrics, Umea, Sweden). Principal compo-
nent analysis (PCA) and orthogonal projection to latent 
structures discriminant analysis were used to examine 
UPLC-MS data in a multivariate setting. Before model 
fitting, features were subjected to Pareto scaling. Two-
tailed t test assuming unequal variance and coefficient 
of variation percentage were calculated in Microsoft 
Office Excel 2007 (Redmond, WA). P values were 
adjusted for multiple comparisons using the Benjamini-
Hochberg method in R programming software.
MetaBolIte aSSIgNMeNt
Metabolite identification by MS was conducted 
by matching accurate m/z measurements of detected 
chromatographic peaks to theoretical values from 
in-house databases and online databases (Human 
metabolite database [HMDB]; http://www.hmdb.ca/), 
Kyoto Encyclopedia of Genes and Genomes (KEGG; 
http://www.genome.jp/kegg/ligand.html),   LIPID 
MAPS (http://www.lipid maps.org/tools/ index.html), 
and METLIN (http://metlin.scrip ps.edu/)). Tandem 
MS fragmentation patterns were obtained for further 
structural elucidation. Assignment was confirmed by 
the comparison of retention times and MS/MS data 
with authentic standards (details available on request).
tISSUe mRNa eXpReSSIoN
Total RNA from duodenum, distal ileum, and liv-
ers of mice was extracted and quantified with real-
time PCR, as described in the Supporting Methods.
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tISSUe pRoteIN eXpReSSIoN
Distal ileal ASBT protein levels were measured 
using western blotting, as described in the Supporting 
Methods.
StatIStICal aNalySIS
Statistical techniques are detailed within each section 
of the methodology. For all comparisons between groups, 
appropriate statistical tests were selected based upon the 
normality of data distribution, with P < 0.05 used as the 
threshold for significance following correction for mul-
tiple comparisons. Unless otherwise indicated, statistical 
tests were performed in R (R Foundation), Microsoft 
Excel (Redmond, WA) or Graphpad Prism (GraphPad 
Software Inc, San Diego, CA).
Results
pRegNaNCy IS aSSoCIateD 
WItH ReDUCeD eNteRoHepatIC 
BIle-aCID/FXR–MeDIateD 
SIgNalINg
Fasting and peak FGF19 and C4 levels were 
measured in serum of women taking a standardized 
diet for 24  hours. Women in the third trimester of 
pregnancy had reduced peak FGF19, demonstrating 
reduced intestinal FXR signaling and enterohepatic 
feedback (Fig. 1A). This reduction was consistent 
with the increased gestational hepatic bile acid syn-
thesis demonstrated by elevated fasting serum concen-
trations of C4 (Fig. 1B). Lowered FGF19 levels were 
not explained by intestinal FXR inhibition by PM5S, 
which increases in normal pregnancy and can impair 
hepatic FXR induction, given that CDCA-induced 
FXR induction was not affected by co-treatment with 
PM5S in terminal ileal explants (Supporting Fig. 
S2). Because bile acid species have different poten-
cies as FXR agonists, fecal bile acids were measured. 
There were minimal differences between nonpregnant 
women and those in the third trimester of uncompli-
cated pregnancies (Fig. 1C). However, the majority of 
fecal bile acids will be deconjugated by colonic bac-
terial activity by the time they are excreted in feces, 
and therefore this result is unlikely to reflect the bile 
acid content of the terminal ileum, the site of maximal 
enterocyte FXR expression. To address this issue, cecal 
contents were collected from C57BL/6 pregnant mice.
MURINe pRegNaNCy IS 
CHaRaCteRIZeD By IMpaIReD 
INteStINal FXR SIgNalINg, 
WItH alteReD INteStINal 
BIle aCID CoNJUgatIoN
To determine the influence of pregnancy on intestinal 
tissues, terminal ileal and cecal samples from C57BL/6 
mice were examined. Terminal ileal FXR induction of 
FGF15 and SHP was reduced on day 18 of murine 
pregnancy (Fig. 2A). Whereas expression of ASBT 
mRNA did not differ significantly in pregnancy, despite 
its usual repression by SHP (Fig. 2A), ASBT protein 
levels were significantly reduced (Fig. 2B). Consistent 
with the human explant models, PM5S did not repress 
terminal ileal FXR induction in mice that received 
PM5S gavage compared to vehicle (Supporting Fig. S3). 
Given the gestational reduction in terminal ileal FXR 
induction, we determined hepatic mRNA expression of 
genes of relevance to bile acid homeostasis, to establish 
whether these intestinal signals contribute to hypercho-
lanemia (Supporting Fig. S4A). There were gestational 
reductions in mRNA expression of Fxr target genes as 
has been described.(4) Intriguingly, there was reduced 
transcription of cytochrome P450 family 7 subfamily A 
member 1 (Cyp7a1) at day 18 of pregnancy, a result that 
is not consistent with reduced bile acid synthesis. Because 
murine pregnancy is associated with hypercholanemia 
with advancing gestation, which could repress Cyp7a1 at 
the hepatocyte,(3) we quantified hepatic Cyp7a1 expres-
sion in mice throughout pregnancy and demonstrated a 
significant increase at day 7 of pregnancy, which fell by 
day 14 (Supporting Fig. S4B).
Targeted UPLC-MS/MS evaluation of cecal 
content demonstrated lower conjugated and sulfated 
bile acids in pregnancy (Fig. 2C,D; Supporting 
Table S2), with proportionately more secondary 
(DCA, ω-MCA) than primary bile acids (CA, 
α-MCA, β-MCA) than in age-matched nonpregnant 
mice (Fig. 2E). The reduction in conjugated bile 
acids in the cecum in pregnancy did not result from 
lower hepatic bile acid conjugation, given that the 
bile acid profiles of liver and gall bladder did not 
reveal altered conjugation proportions in pregnancy 
(Supporting Fig. S5).
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tHe CeCal MICRoBIoMe 
oF MURINe pRegNaNCy 
HaS eleVateD Bacteroidetes, 
WItH eNHaNCeD BIle Salt 
HyDRolaSe geNeS aND BIle 
Salt DeCoNJUgatIoN
Given that the cecal bile acid composition was 
likely altered by the intestinal bacterial modification, 
whole shotgun genome metagenomic sequencing 
was used to characterize the effect of pregnancy on 
the murine cecal microbiota. Pregnancy was associ-
ated with a higher ratio of Bacteroidetes to Firmicutes, 
with increased richness and diversity (Fig. 3A-C; 
Supporting Table S3). Targeted metagenomics con-
firmed the pregnant microbiome encoded bile salt 
hydrolase (Bsh), which deconjugates bile acids; further 
analysis revealed this to be encoded by the genome 
FIg. 1. Human pregnancy reduces enterohepatic feedback, without alteration in fecal bile acids. (A) FGF19 and (B) C4 in serum of 
14 nonpregnant women and 24 pregnant women with uncomplicated pregnancies while fasting (8:00 am) and 3 hours postprandial 
(3:00 pm), following a standardized diet. Boxes show interquartile range (IQR) with whiskers at 1.5 IQR. Groups compared with 
two-way analysis of variance (ANOVA) and Tukey testing for multiple comparisons. (C) Bile acid profile of fecal samples from women 
outside of pregnancy (dark gray bars, n = 9) and with uncomplicated pregnancies (light gray bars, n = 14). Bars show mean ± SEM. 
Significance determined by two-way ANOVA with Tukey’s multiple comparison test. Abbreviations: GCA, glycocholic acid; GCDCA, 
glycochenodeoxycholic acid; GDCA, glycodeoxycholic acid; HCA, hyocholic acid; HDCA, hyodeoxycholic acid; TCA, taurocholic 
acid; TCDCA, taurochenodeoxycholic acid; TDCA, taurodeoxycholic acid; UDCA, ursodeoxycholic acid.
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FIg. 2. Murine pregnancy is characterized by reduced enterohepatic feedback with an altered cecal bile acid profile. (A) Expression 
levels of FGF15, SHP, and ASBT mRNA in murine distal ileum of nonpregnant and pregnant (day 18) mice, assessed by multiple 
measures of analysis of variance (ANOVA) with Tukey post-hoc testing. Boxes show interquartile range (IQR) with whiskers at 1.5 
IQR, N = 6-8. (B) Protein levels of ASBT in murine distal ileum determined by western blotting for nonpregnant and pregnant mice 
(n = 8 and n = 5), normalized to βactin. Groups compared with Mann-Whitney U test. (C) Ratio of conjugated to unconjugated bile 
acids in the cecal content of nonpregnant and pregnant mice. Boxes show IQR with whiskers at 1.5 IQR, N = 6-8. (D) Distribution of 
cecal bile acids by conjugation in the cecal content of nonpregnant and pregnant mice. N = 6-8. (E) Relative quantification of individual 
bile acids present in cecal content of nonpregnant and pregnant mice. Assessed by Student t test, with Benjamini-Hochberg correction, 
results show mean + SEM, N = 6-8. Abbreviations: HCA, hyocholic acid; HDCA, hyodeoxycholic acid; MDCA, murideoxycholic 
acid; TCA, taurocholic acid; TDCA, taurodeoxycholic acid; THDCA, taurohyodeoxycholic acid; TUDCA, tauroursodeoxycholic 
acid; UDCA, ursodeoxycholic acid.
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FIg. 3. Pregnancy alters the murine cecal microbiota and microbiome. (A) Distribution of cecal microbiota by phylum level for 
nonpregnant and pregnant mice. N = 6-8. (B) Chao 1 richness and (C) Shannon evenness of microbial communities for nonpregnant 
and pregnant mice. Box-whisker plots demonstrate median (thick line) and interquartile range (IQR) with whiskers at 1.5 IQR. 
Differences between groups determined by Kruskal-Wallis univariate analysis. N = 6-8 throughout. (D) Bsh and (E) aryl sulfatase (Ars) 
gene reads in the cecal microbiome of nonpregnant and pregnant mice. Difference between groups determined by two-tailed t test. 
N = 6-8 throughout. Abbreviation: ns, not significant (P ≥ 0.05).
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of bacteria of the Bacteroidetes phylum (Fig. 3D). 
Similarly, the microbiome of pregnant mice included 
genes for aryl sulfatases, also Bacteroidetes derived, 
which were not present outside pregnancy (Fig. 3E). 
7-α-dehydroxylase sequences from the Uniprot library 
were not identified in the microbiome of either group. 
However, none of these sequences originates from 
Bacteroidetes, which are likely to have contributed to 
the production of secondary bile acids.
tHe geStatIoNal MURINe 
CeCal MetaBoNoMe 
MaRKeDly DIFFeRS FRoM 
NoNpRegNaNt MICe, WItH 
loWeR taURINe SeCoNDaRy to 
ItS BaCteRIal MetaBolISM
Given the multiple metabolic actions of intestinal 
bacteria, untargeted UPLC-MS/MS was performed to 
FIg. 4. Pregnancy alters the murine cecal metabonome. Metabolite changes in the cecal content between nonpregnant and pregnant 
mice. (A) Significance of metabolite changes, log (P value) of t test (two-tailed; assuming unequal variance) and (B) fold change for 
the same metabolites. P values adjusted for multiple comparisons using the Benjamini-Hochberg method. N = 6-8. Abbreviations: 
Cer, ceramide; DG, diacylglycerol; HexCer, hexosylceramide; PA, phosphatidic acid; PE, phosphatidylethanolamine; PC, 
phosphatidylcholine; SM, sphingomyelin. N = 6-8.
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identify metabolites that were significantly altered in the 
cecal content of pregnant mice (Fig. 4A,B; summary of 
model characteristics in Supporting Table S4). Taurine 
was significantly reduced in pregnancy, despite the 
increased deconjugation inferred by cecal bile acid pro-
files and bacterial BSH. The cecal microbiota in preg-
nancy was enriched with sulfur-utilizing bacteria, such 
as the Proteobacteria Bilophila (Supporting Table S3); 
FIg. 5. CA supplementation enhances enterohepatic feedback and alters the cecal bile acid profile. (A) Expression levels of FGF15 
and (B) SHP mRNA in murine distal ileum of nonpregnant chow- and CA-fed mice and pregnant CA-fed mice, assessed by multiple 
measures of analysis of variance with Tukey post-hoc testing. Boxes show interquartile range (IQR) with whiskers at 1.5 IQR, N = 6-8. 
(C) Distribution of cecal bile acids by conjugation in the cecal content of nonpregnant chow- and CA-fed and pregnant CA-fed 
mice. N = 6-8. (D) Relative quantification of individual bile acids present in cecal content of nonpregnant chow- and CA-fed mice 
and pregnant CA-fed mice. Assessed by two-tailed t test, with Benjamini-Hochberg correction; bars show mean + SEM, N = 6-8. 
Significance determined by P < 0.05; a: nonpregnant chow- versus nonpregnant CA-fed mice; b: nonpregnant CA-fed versus pregnant 
CA-fed mice; c: nonpregnant chow-fed versus pregnant CA-fed mice. Abbreviations: HCA, hyocholic acid; HDCA, hyodeoxycholic 
acid; MDCA, murideoxycholic acid; TCA, taurocholic acid; TDCA, taurodeoxycholic acid; THDCA, taurohyodeoxycholic acid; 
TUDCA, tauroursodeoxycholic acid; UDCA, ursodeoxycholic acid.
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these likely utilized the liberated taurine from 
Bacteroidetes BSH bile acid deconjugation, or sulfur 
following aryl sulfatase activity, as a growth substrate. 
Untargeted metabonomics did not detect any dif-
ferences in known FXR ligands, although the RXR 
ligands, docosahexaenoic acid, arachidonic acid, and 
docosapentaenoic acid,(30) were increased in pregnancy.
Ca FeeDINg oF MICe 
ReVeRSeD tHe geStatIoNal 
IMpaIRMeNt oF FXR-MeDIateD 
eNteRoHepatIC FeeDBaCK
Given that these results suggest that the impair-
ment in FXR-mediated enterohepatic feedback in 
pregnancy is attributed to altered intestinal bile acid 
species availability, with reduced terminal ileal uptake 
attributed to the lower ASBT affinity of unconjugated 
bile acids, we sought to identify whether this could be 
overcome with an increased intestinal bile acid load. A 
diet supplemented with 0.5% CA was fed to pregnant 
C57BL/6 mice and to age-matched nonpregnant mice. 
CA-supplemented mice had increased terminal ileal 
FXR induction, with elevated FGF15 mRNA expres-
sion (Fig. 5A). Similarly, CA-fed mice did not have the 
suppression of SHP (Fig. 5B) that is observed in normal 
gestation. Supplementation with CA altered the cecal 
bile acid composition, with increased CA and its bac-
terially derived metabolite, DCA (Fig. 5C,D). CA-fed 
mice had very low cecal MCA species; these are depen-
dent upon murine hepatic synthesis, confirming that 
CA supplementation overcame the gestational impair-
ment in FXR-mediated enterohepatic feedback.
Ca SUppleMeNtatIoN HaD 
SIMIlaR eFFeCtS oN tHe 
CeCal MetaBoNoMe to 
pRegNaNCy
To support the hypothesis that intestinal induction 
of FXR resulted from the altered bile acid profile, 
untargeted metabonomics was performed. CA supple-
mentation resulted in very similar metabolite profiles 
to pregnancy (Figs. 4 and 6).
tHe geStatIoNal 
alteRatIoNS to tHe CeCal 
MICRoBIota aRe eNHaNCeD IN 
Ca-SUppleMeNteD MICe
CA supplementation enriched the gut microbiota 
with Bacteroidetes and Proteobacteria, with reduced 
Firmicutes, similar to the changes observed in preg-
nancy (Fig. 7), although the increased richness and 
diversity was only demonstrated in the pregnant 
CA-fed mice. Whereas pregnancy ameliorated the 
CA-feeding enhancement of Sutterella and Prevotella, 
the pregnancy-associated increase of Dehalobacterium 
was observed irrespective of CA supplementation. 
Additionally, CA supplementation enhanced bacte-
ria encoding genes for BSH expression. Ordination 
methods of comparing the cecal metabonome and 
microbiota demonstrated that CA feeding enhances 
the gestational changes observed (Fig. 8A,B). A heat-
map correlating individual microbial and metabolite 
levels for the different murine groups demonstrated 
that the alterations observed were particularly similar 
for both gestational and CA-feeding effects (Fig. 8C), 
demonstrating the critical inter-relationship between 
the gut microbial profile and metabolite composition. 
In both groups, the taurine-conjugated bile acids were 
negatively correlated with the microbes that became 
more abundant in pregnancy (Bacteroides, Odoribacter, 
Prevotella, Bilophila, and Desulfovibrio), and they had 
a positive correlation with those that were reduced 
(Parabacteroides and Bulleidia). Taurine showed similar 
correlations with the microbiota to the taurine- 
conjugated bile acids, and there was an increased abun-
dance of microbes that are known to utilize taurine for 
energy in the cecal content of pregnant and CA-fed 
animals, such as Bilophila and Desulfovibrio spp. Of the 
phospholipids, lysophos pha tidyleth anolamines (LPEs) 
FIg. 6. CA dietary supplementation alters the murine cecal metabonome. Metabolite changes in the cecal content between, from 
left to right, nonpregnant chow- and nonpregnant CA-fed mice, and nonpregnant CA- and pregnant CA-fed mice. (A) Significance 
of metabolite changes, log (P value) of t test (two-tailed; assuming unequal variance) and (B) fold change for the same metabolites. 
P values adjusted for multiple comparisons using the Benjamini-Hochberg method. N  =  6-8. Abbreviations: Cer, ceramide; DG, 
diacylglycerol; HexCer, hexosylceramide; PA, phosphatidic acid; PE, phosphatidylethanolamine; PC, phosphatidylcholine; SM, 
sphingomyelin. N = 6-8.
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and lysophosphatidylcholines (LPCs) positively cor-
related with the microbes that were increased in preg-
nancy and CA feeding (e.g., Bacteroides, Oridobacter, 
Prevotella, Bilophila, and Desulfovibrio) and negatively 
correlated with those that were reduced (Bulleidia, 
Coprococcus, and Parabacteroides). The only exception 
was LPE (17:1), which had the reverse correlation. 
For pregnant CA-fed mice, the associations between 
metabolites and microbiota more closely reflected 
those observed for CA-fed mice than pregnancy alone 
(e.g., for inosine, docosenoic acid, tetracosanoic acid, 
diacylglycerol, and the bile acids), although this was 
not universal (e.g., taurine).
Using the metagenomic functional analysis and 
metabolite results, the effects of pregnancy, CA feed-
ing, and CA feeding in pregnancy on metabolic path-
ways of the mice (host) and microbiota (colonizer) 
were determined. Results were strikingly similar for 
the effects of pregnancy and CA feeding, especially 
with respect to the predicted induction of host hepato-
toxic pathways (Supporting Table S5). Overlap in the 
pregnancy/CA-fed comparators is illustrated in the 
significantly altered toxicology functions (Supporting 
Fig. S6), diseases, and biofunction pathways and 
canonical pathways (Supporting Figs. S7 and S8). 
Specifically, for normal pregnancy, the 10 most sig-
nificantly altered toxicological functions included six 
functions implicated in liver damage or liver steato-
sis, and eight such pathways were altered in CA-fed 
animals, the majority of which were the same as in 
normal gestation (Supporting Fig. S6). Pathway anal-
yses further revealed the cecal microbiome of preg-
nancy and CA feeding in mice to have significantly 
increased abundance of genes encoding components 
of the glycine cleavage system (Supporting Fig. S9), 
consistent with utilization of glycine as an additional 
energy source, likely available following the additional 
deconjugation of glycine-conjugated bile acids.
Discussion
Our results demonstrate that normal pregnancy is 
associated with impaired FXR-mediated enterohe-
patic feedback and elevated hepatic bile acid synthe-
sis, which is consistent with the elevation in serum 
primary bile acids (CA > CDCA) observed in human 
pregnancy.(1) We concluded that this impairment 
results from an altered intestinal bile acid composition 
secondary to gestational changes in the gut microbi-
ota, with enhanced Bacteroidetes-mediated bile acid 
deconjugation in combination with reduced termi-
nal ileal bile acid uptake in pregnancy secondary to 
lower ASBT protein levels. Direct signaling from the 
gut bacteria to FXR or other alterations in the gut 
metabonome are unlikely to cause this impairment in 
enterohepatic feedback, given that CA dietary sup-
plementation resulted in a very similar gut microbi-
ome and metabolome to pregnancy, yet resulted in 
induction of enterohepatic feedback. Pregnant and 
CA-supplemented mice had increased cecal ratios of 
Bacteroidetes to Firmicutes, with additional enrichment 
of sulfur-reducing bacteria. Bile salt hydrolase was 
exclusively detected in the genome of the Bacteroidetes 
present in these animals, and these mice had propor-
tionately more cecal unconjugated bile acids.
The elevation in serum bile acids in pregnancy 
has previously been attributed to reduced entero-
hepatic cycling,(31) consistent with reduced FXR 
function and bile salt export pump induction(4,7); 
our demonstration of elevated fasting C4, in partic-
ular, supports altered regulation of bile acid synthe-
sis in pregnancy, likely secondary to reduced FXR 
function and resultant lowering of SHP-mediated 
impairment of CYP7A1. Whereas we demonstrated 
reduced Cyp7a1 mRNA expression at day 18, the 
increased transcription at day 7 is consistent with 
hepatic FXR inhibition; protein quantification and 
FIg. 7. CA dietary supplementation alters the murine cecal microbiota in similar ways to pregnancy. (A) Distribution of cecal 
microbiota by phylum level for nonpregnant chow- and CA-fed mice, and pregnant CA-fed mice. N = 6-8. (B) Bsh and (C) aryl sulfatase 
(Ars) gene reads in the cecal microbiome of nonpregnant and pregnant mice. Box-whisker plots demonstrate median (thick line) and 
interquartile range (IQR), with whiskers at 1.5 IQR. Differences between groups determined by one-way analysis of variance with 
Tukey’s multiple comparison test. N = 6-8. (D) Chao 1 richness and (E) Shannon evenness of microbial communities for nonpregnant 
and pregnant mice. Box-whisker plots demonstrate median (thick line) and IQR, with whiskers at 1.5 IQR. Differences between groups 
determined by Kruskal-Wallis univariate analysis. N = 6-8 throughout. (F) Taxonomic tree of microbes identified at genus level found 
to significantly differ after separate comparisons of nonpregnant chow- versus pregnant chow-fed (gray), nonpregnant chow- versus 
nonpregnant CA-supplemented diet (orange), pregnant chow- versus pregnant CA-supplemented diet (green), and nonpregnant CA- 
versus pregnant CA-supplemented diets (purple). Arrow direction indicates relative abundancy in the second of the comparator groups. 
Significance defined as P < 0.05 by White’s nonparametric t test with Benjamini-Hochberg correction.
Hepatology, Vol. 0, No. 0, 2019 OVADIA, PERDONES-MONTERO, ET AL.
15
Hepatology, Month 2019OVADIA, PERDONES-MONTERO, ET AL.
16
activity assays would be required to confirm this 
mechanism of increased gestational bile acid syn-
thesis. Herein, we provide an additional explana-
tion, that increased hepatic bile acid synthesis is 
secondary to reduced enterohepatic feedback, which 
is consistent with the previous murine study of 
Moscowitz et al.(32) A limitation of our study was 
that we did not measure the complete bile acid pool 
size and total bile acid excretion, to confirm that 
increased bile acid synthesis was not compensatory 
to increased fecal bile acid loss.
Alterations in the intestinal bile acid composition, 
resulting from bacterial bile acid modification, could 
impact enterocyte FXR induction in two ways: by 
impairing bile acid uptake by the enterocyte and/
or by changing the proportion of agonistic bile acid 
ligands compared with the antagonists. ASBT bind-
ing of bile acids is thought to be the rate-limiting 
step in the uptake of bile acids from the lumen to 
terminal ileal enterocytes, and ASBT preferentially 
binds conjugated bile acids (reviewed in a previous 
work(33)). Thus, we hypothesize that the proportion-
ate reduction in conjugated bile acids in pregnancy, 
secondary to bacterial activity, reduces the amount 
of bile acids absorbed in the terminal ileum, the 
predominant site of FGF19/15 synthesis. Whereas 
there was no reduction in ASBT mRNA induction 
in pregnancy, ASBT protein levels were reduced in 
the distal ileum, which likely contributed further to 
the reduced intestinal FXR induction.
Established ligand potencies of the bile acids pres-
ent in the pregnant cecal content are consistent with 
altered FXR induction as a consequence of the dif-
ferent balance of agonistic bile acids, such as CDCA 
and DCA species,(17) with antagonistic bile acids, 
such as the tauromuricholic acids (TMCAs).(15) 
The profile of cecal bile acids in pregnant mice did 
not suggest that these mice would have associated 
impairment of intestinal FXR function, given that 
there were significant reductions in the antagonistic 
species.
The similarities in the intestinal metabonome and 
microbiota between the pregnant and CA-fed mice 
were surprising, given the markedly different bile acid 
loads to the intestine. Our findings are in contrast to 
those of CA dietary supplementation in rats, where 
increased cecal CA and DCA induced expansion of 
the Firmicutes, particularly the Clostridia class.(34) 
This may have been attributed to the increased lyso-
phospholipids (LPE/LPC) in the cecal content; these 
lysophospholipids are bactericidal to Gram-negative 
bacteria, particularly anaerobes such as Clostridia.(35,36) 
Given the structural similarity of steroid hormones to 
bile acids, the gestational increases in estrogens, pro-
gestogens, and corticosteroids, present in bile (reviewed 
by Begley et al.(37)), may provide similar bacterial selec-
tion pressures to those of bile acid feeding. Indeed, 
steroid hormones, such as 17α-hydroxyprogesterone, 
estradiol, and progesterone, are both inhibitory and 
stimulatory to growth of different bacteria.(38-40)
In summary, we have demonstrated alterations in 
the intestinal microbiome and metabonome in preg-
nancy that could impair enterohepatic feedback on bile 
acid synthesis and contribute to the hypercholanemia 
of pregnancy. Particularly given that the secondary 
bile acids, DCA and lithocholic acid (LCA), are also 
potent ligands for the TGR5 receptor at enteroendo-
crine L cells, the altered microbial modification of bile 
acids in pregnancy may explain the increasing levels of 
GLP1 with advancing gestation.(41) Future studies are 
needed to establish precisely how gestational signals 
are capable of dramatically impacting the gut microbi-
ome during pregnancy, and whether these gestational 
signals can be manipulated to enhance beneficial met-
abolic changes for the pregnancy. This understanding 
will be of importance for the treatment of such ges-
tational metabolic disorders as intrahepatic cholestasis 
of pregnancy and gestational diabetes mellitus.
FIg. 8. Comparison between metabonome and microbiome of mouse cecal content by diet and pregnancy status. (A) Scores plot of 
PCA of the cecal content extracts generated from the UPLC-MS analysis (dark blue, nonpregnant chow-fed; light blue, pregnant 
chow-fed; red, nonpregnant CA-supplemented diet; yellow, pregnant CA-supplemented diet). PC1 explains 27% variance of the data 
set, and PC2 explains 13.6%. (B) Scores plot of principal coordinates analysis (PCoA) of the cecal content from the microbiome 
weighted Unifrac analysis (dark blue, nonpregnant chow-fed; light blue, pregnant chow-fed; red, nonpregnant CA-supplemented diet; 
yellow, pregnant CA-supplemented diet). PC1 explains 64% variance of the data set, and PC2 explains 12.6%. (C) Correlation matrix 
(Spearman correlation) of metabolites (y-axis) and microbes (x-axis) found to be significantly different after separate comparisons of 
nonpregnant chow- versus pregnant chow-fed, nonpregnant chow- versus nonpregnant CA-fed, and pregnant chow- versus pregnant 
CA-fed mice. N = 6-8 throughout.
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